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Introduction
Morphine withdrawal is a common medical problem. Patients with morphine withdrawal can present with a variety of symptoms including runny nose, watery eyes, fever, vomiting, nausea, headaches, sweating, chills, muscle aches, diarrhea, high blood pressure, agitation, anxiety, irritability, depression, disorientation, insomnia 1 . This case report describes a seizure as a clinical complication during an adult male patient's withdrawal from morphine. The link between opioid withdrawal and seizures is not well studied in adult humans. To the best of our knowledge, only two case series of seven patients and three patients have been reported tying opioid withdrawal to seizures 2,3 .
Case presentation
A 44-year-old Qatari man known to have persistent back pain admitted to our facility in 2017. He presented with left lower extremity edema that started approximately three to four weeks prior to admission. It was affecting his daily activities like showering and driving. The edema began in his foot and then gradually progressed to his abdomen. A physical examination found soft pitting edema in the left lower limb up to the sacrum posteriorly and to the umbilicus anteriorly. His lower limb showed some redness with no hotness, tenderness, or signs of chronic venous insufficiency. His past surgical history demonstrated multiple back surgeries, as follows; in 1986, he underwent surgical correction and fusion of lumbar scoliosis anteriorly and posteriorly. Additionally, in 1986, he had triple arthrodesis of his right foot. In 1992, he underwent lengthening of his atrophic flail right leg. In 1993, the Harrington rod from the dorsal and lumbar spine was removed. In 2004, he had anterior lumbar interbody fusion with cages at the levels of T10-T11 and T11-T12. In 2008, he underwent revision surgery to extend the anterior instrumentation from T2 to T12. In March of 2014, the patient had intrathecal morphine pump inserted with a morphine infusion rate of 5.75 mg/day. Upon admission, a Doppler ultrasound scan of his left lower limb revealed no evidence of deep vein thrombosis ( Figure 1 ). The patient was started empirically on amoxicillin-clavulanic acid (875 mg orally every 12 hours for five days), suspecting community-acquired cellulitis as one of the common causes of unilateral lower limb edema, but his edema did not improve. On the fifth day of admission, the patient started to develop new edema on the right leg. A pelvic and abdominal ultrasound scan showed no obvious mass ( Figure 2 ). We then suspected that his intrathecal morphine infusion may be the cause of his peripheral edema, as other common causes were excluded, so the morphine pump was halted, and the pain management team initiated the patient on oral morphine (30 mg) twice daily and tramadol (50 mg) every six hours.
After twelve hours from pump termination, the patient started to convulse. He had three episodes of convulsion over two hours in the form of generalized tonic-clonic convulsion with rolled-up eyes; each episode was preceded by progressive muscle twitches. They were associated with continuous high blood pressure, ranging from 180/100 mmHg to 210/110 mmHg, and profuse sweating. All of the seizure episodes were aborted within a few seconds following the administration of 5mg intravenous diazepam, which was administered one to two minutes after the seizure started. Four hours later, another three seizure episodes occurred. The first was aborted by 5mg intravenous diazepam and the other two episodes required 10mg of intravenous diazepam.
A computed tomography review of the patient's head was grossly normal and revealed no acute intracranial event (Figure 3) . A complete metabolic panel was done and revealed no acute metabolic process or hypoglycemia. The patient's morphine regimen changed to 5 mg administered intravenously every four hours with oral tramadol (50 mg) every six hours. In the evening, the patient regained full consciousness and no additional seizures occurred.
Upon patient request, the intrathecal morphine pump was restarted. One day after, the patient's swelling in left lower limb started to increase so the intrathecal morphine pump was stopped, and the patient was started on patient-controlled analgesia fentanyl (50 mcg/hour) and oral methadone (10 mg every six hours). His left-and right-side edema disappeared gradually over seven days and after he regained his baseline functional capacity, he was discharged.
Discussion
Central nervous system irritability is a known opioid withdrawal sign in neonates 4 and is accompanied by seizures in 2% to 11% of cases 5,6 . While a high degree of cerebral activity and seizure has been reported in rodent model opioid withdrawal studies 7 , the link between opioid withdrawal and seizures is not well studied in adult humans. To the best of our knowledge, only two case series of seven patients and three patients have been reported tying opioid withdrawal to seizures 2,3 .
Our patient was not known to be an opioid addict from their history and their opioid risk tool score of one 8 , so the concurrent use of another known seizure-inducing substance was unlikely. He was receiving an intrathecal dose of morphine which changed to an unequal oral dose of morphine, in addition to tramadol. Seizures are not mentioned in the literature as a known complication of morphine withdrawal, and the patient's complication may have been caused by severe pain accompanied by inadequate doses of analgesics.
Conclusions
This case illustrates a possible connection between opioid withdrawal and seizure in an adult male patient. Seizure is a Reviewer Expertise: Addiction Psychiatry, Child Psychiatry, Resilience in wifes of alcoholism, I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.
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